Travere Therapeutics, Inc (TVTX)

(10% Negative) Travere Therapeutics, Inc (TVTX) Announces Delay in positioned Trials for successful commercial launch of FILSPARI in FSGS Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Phreesia Inc (PHR)

Director Indig Chaim 🔴 sold 8.4K shares of Phreesia, Inc. (PHR) at $17.01 Transaction Date: Jan 08, 2026 | Filing ID: 000015

Zymeworks Inc (ZYME)

📋 Leone D Patterson (Ex-officer) plans to sell 7K shares of Zymeworks Inc. (at $23.17 each, total $158K) Filed: Jan 12, 2026 | ID: 010578